Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients

Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., Nov. 6, 2025 /PRNewswire/ -- CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous...